Weclome RSC Members
We are honored to welcome Drs. John S. Lazo and Patrick C. May to our Research Strategy Council (RSC). The RSC is composed of six extraordinary individuals with a wide range of relevant expertise. The council is tasked with assessing the entire portfolio of funded research to ensure the organization is active in the right areas of investigation, and that the approved grants are fully aligned with the goal of accelerating the development of a disease-altering treatment or cure for Alzheimer’s disease.
Leverage 7.5X
Our grants for proof-of-concept research provide the necessary data and de-risking, leading to follow-on funding from the National Institutes of Health / National Institute on Aging and other investors. As an illustration of this strength, our 2020 research portfolio with distributions totaling $14 million led to additional funding from the NIH / NIA of $106 million, a return of 7.6X. For the combined years of 2018 through 2020, the total of $47 million in grants provided to researchers from Cure Alzheimer’s Fund resulted in an extraordinary $350 million of follow-on funding from NIH / NIA. For the three years of 2018 through 2020 combined, the return of follow-on funding from the NIH / NIA is 7.5X.
Key Numbers for 2022 are in!
We are pleased to provide you with our annual infographic which has been updated for our 2022 results
Ways to Contribute to Our Research
You may wish to provide support for Alzheimer’s disease research as part of the plan for your estate. One way to contribute is through Qualified Charitable Distributions (QCD’S), paid directly from an Individual Retirement Account to a charity, and may provide tax advantages.
Thank You!
Thank you to the many friends of Cure Alzheimer’s Fund for your support of our research. It is through your generosity that our researchers have made significant advancements in understanding the underlying causes of Alzheimer’s disease.
—The Cure Alzheimer’s Fund Team